BUSINESSJun 4 · 13:06 UTCFRANCE 24Kate MOODY

Pharmaceutical industry becomes geopolitical battleground as US threatens tariffs

The global pharmaceutical industry is caught in geopolitical and trade tensions as the Trump administration threatens tariffs on manufacturers or countries to promote US drugmaker sovereignty and reduce prescription drug prices for Americans.

Nexus surfaces and summarizes. The full story lives at the source.

Mentioned

Trump administrationorganizationpharmaceutical industrytopicUnited Statesplace

Spot something wrong with this article?Report a problem →

Forward this

Related Signal

Adjacent reporting

BUSINESSApr 2 · 19:50 UTC
Trump administration announces new tariffs on drugmakers
WORLDApr 8 · 13:44 UTC
Trump threatens tariffs on any country supplying military weapons to Iran
HEALTHApr 22 · 00:41 UTC
What medications are at risk as Strait of Hormuz blockade threatens supply chain
WORLDApr 9 · 23:33 UTC
Ecuador hikes tariffs to 100-percent in feud with neighbour Colombia
BUSINESSMay 30 · 13:35 UTC
The U.S.-China rivalry is killing global supply chains. Your portfolio needs a ‘home court advantage.’
BUSINESSMay 25 · 10:26 UTC
Europe pushes back on Chinese trade dominance